Hypertension
Conditions
Keywords
hypertension, blood pressure
Brief summary
The overall goal of this project is to determine if measuring blood pressure at home and staying in contact with a team of pharmacists and physicians to manage your blood pressure is feasible. The study will enroll 24 participants at UAB who are seen at the Emergency Department Post-Discharge Clinic. Half of the participants (12 patients) will be asked to measure their blood pressure at home, and half of the participants (12 patients) will continue to receive usual care. Participants who measure their blood pressure at home will also meet with a pharmacist weekly over the phone to discuss blood pressure readings and have blood pressure medications prescribed if needed. This program will last 3 months.
Detailed description
For all participants: 1. Participants will receive information on the importance of measuring blood pressure and ways to improve blood pressure. 2. Participants will complete questionnaires describing current socioeconomic position, medical history and healthcare needs. 3. Participants will come in for one research clinic visit to get blood pressure measured 3 months after enrollment in this study. For participants asked to measure blood pressure at home: 1. Measure blood pressure twice a day at home, following the instructions provided. The study will provide participants with the device and send text message reminders each week day. Participants will return the device at study visit 3 months from now. 2. Following the instructions provided, participants will talk to a pharmacist over the phone weekly to discuss blood pressure and medications. All medication changes will be discussed with a collaborating physician. 3. Participants will complete questionnaires on satisfaction with the program.
Interventions
Remote blood pressure monitoring and pharmacist led telehealth intervention for blood pressure management
OTHERUsual care
Participants receive usual care, no intervention.
Sponsors
University of Alabama at Birmingham
National Institute on Minority Health and Health Disparities (NIMHD)
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients seen at the Emergency Department Post-Discharge Clinic * \>=18 years * Blood pressure \>=130/80 mmHg and \<=160/100 mmHg * English speakers * Have a smartphone
Exclusion criteria
* Patients with blood pressure \>=160 mmHg
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Total Number of Recruited Participants | 2 years | Number of participants enrolled into the study after screening and eligibility confirmation. |
Countries
United States
Contacts
PRINCIPAL_INVESTIGATORLama Ghazi, MD, PhD
University of Alabama at Birmingham
Participant flow
Recruitment details
27 participants were screened and 24 were eligible and were enrolled.
Pre-assignment details
24 participants who were eligible were enrolled.
Baseline characteristics
| Characteristic | — |
|---|---|
| Age, Continuous | 48.2 years STANDARD_DEVIATION 13.6 |
| Race (NIH/OMB) American Indian or Alaska Native | 0 Participants |
| Race (NIH/OMB) Asian | 0 Participants |
| Race (NIH/OMB) Black or African American | 8 Participants |
| Race (NIH/OMB) More than one race | 0 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 1 Participants |
| Race (NIH/OMB) White | 5 Participants |
| Sex: Female, Male Female | 3 Participants |
| Sex: Female, Male Male | 6 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 12 | 0 / 12 |
| other Total, other adverse events | 0 / 12 | 0 / 12 |
| serious Total, serious adverse events | 0 / 12 | 0 / 12 |
Outcome results
None listed